Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 14, 2018 - The FDA announced the approval of Dr. Reddy’s Laboratories AB-rated generic version of Indivior’s Suboxone (buprenorphine/naloxone) sublingual film.
Download PDF
Return to publications
